[account_shop_links]
Projected Trends from CRO Benchmarking Respondents
Findings from our 2025 CRO Benchmarking studies highlight how clinical trial sponsors are planning for the future. Organizations report strong upward momentum across nearly every innovation‑driven category, with notable increases expected in the use of AI, digital biomarkers, wearable sensors, and adaptive trial designs—signals of a market embracing more efficient, data‑rich, and patient‑centric research models.
Respondents also anticipate an increased focus on enrolling a demographically diverse population and growth in global site utilization beyond the U.S. and Western Europe, underscoring the industry’s push to improve patient diversity in clinical trials. Operationally, sponsors expect rising use of functional service provider (FSP) models and expanded implementation of systems designed to reduce CRO‑management burden, reinforcing the importance of scalability and seamless partnership execution.
Taken together, these trends illustrate a sector aiming to modernize—one that is investing in the technology, partnerships, and global reach required to deliver faster, smarter, and more inclusive clinical development.
View report previews or gain access to our CRO benchmarking research for even more insight on clinical service providers:
- Phase I CRO Benchmarking (17th Ed.): https://isrreports.com/reports/2025-phase-i-cro-benchmarking/
- Phase II/III CRO Benchmarking (17th Ed.): https://isrreports.com/reports/2025-phase-ii-iii-cro-benchmarking/
